Hyprevention was created in 2010 to support the development of Y-STRUT®.
The company is located in Pessac-France, PTIB (Biomedical Innovation – Technical Platform).
Hyprevention develops, manufactures and sells innovative implantable medical devices addressing public health issue.
Cécile Vienney, founder and CEO.
During 2 years, Cécile Vienney was COO at VEXIM sas, a French start-up located in Toulouse, in charge of the development, the approval and the production of medical devices for spine. Alongside, she implemented the operational activities and the team leading in compliance with the European directive 93/42, and got the certification ISO 13485. She hired a team of experts in order to support the project.
Previously, Cécile was Program Manager during 10 years at STRYKER Spine, located in Bordeaux-France. She was in charge of the coordination of marketing, Research and Development, Supply Chain/ industrialization/Production and Quality activities in order to develop and produce ready to sell medical devices. Throughout these experiences, Cécile has developed strong competences in team and project management besides a deep knowledge of industrial issues for the development of orthopedic medical devices in a context of increasingly growing regulatory constraints.
Professor Max Aebi,
Professor and co-president of the Research Center MEM, and Director of the Surgical Orthopedic Evaluation Research Center, at Bern University in Switzerland. Professor Aebi is an international KOL with a huge scientific and surgical expertise. He has spent 10 years at Mc GiIl University, Montréal, where he started working on the hip fracture prevention treatment.
Professor Marek Szpalski,
President of the Orthopedic Surgery and Traumatology Department, at Iris South Teaching Hospital/ Molière Longchamp in Brussels – Belgium, Pr Marek Szpalski is Professor of Orthopedic at Libre University of Brussels. He is also Professor of Orthopedic at New York University.
Doctor Robert Gunzburg, M.D. Ph.D,
Senior consultant in private practice at the Cavell Spine Center of the Edith Cavell Clinic in Brussels and Centenary Clinic in Antwerp, Belgium. Expert for the court of law in matters of general trauma. Past president of the Spine Society of Europe and Deputy-Editor-in-Chief of the European Spine Journal.
Professor Jean-Charles Le Huec,
Director of the DETERCA (Department of Techniques and Applied Surgical Searches (Researches)) Professor at the University Bordeaux Ségalen, Professor Jean-Charles Le Huec has realized numerous research works on the substitutes of the bone tissue, biomechanical studies and by finite elements.
Professor François Cornelis, M.D. Ph.D,
François Cornelis is hospital practitioner at the Universitary Hospital of Bordeaux. Radiologist specialized in oncology and interventional radiology, his research themes are assessment of thermal ablation techniques under imaging guidance (radiofrequency, cryoablation, focused ultrasound) and functional imaging for diagnostic and evaluation applied in oncology.
Doctor Frédéric Deschamps, M.D.,
Dr. Frédéric Deschamps is interventional oncologist. He is hospital physician, specialist of cancer treatment centers at Gustave Roussy Institute and very involved in the treatment of metastases in particular.
June 2010, Agreement with the «Incubateur Régional d’Aquitaine».
December 2010, Agreement with the «Technopole Bordeaux UNITEC».
March 2011, Status of «Jeune Entreprise Innovante» (Young Innovative Company) given by the French Ministery of Higher Education Research.
Association which aims at federating the different stakeholders in the field of gerontechnology and offering a platform for innovative solutions to improve the quality of aging.
BPI France has supported Hyprevention since its creation through grants during the different steps of development of the innovating products and of the company.
Regional Council of Aquitaine has supported Hyprevention since its creation through grants during the different steps of development of the innovating products and of the company.
Aquitaine Regional Incubator – IRA started to support Hyprevention at the stage of the project. During 6 months, IRA has co-financed research and development, as well as intellectual property activities, allowing Hyprevention to develop his project and become a company.
ACCELENCE participates in the clinical study management.
CIC-IT (Clinical Investigation Center – Technological Innovation) helps Hyprevention in its clinical strategy.